ACHILLES THERAPEUTICS PL-ADR (ACHL) Institutional Ownership
None of the superinvestors we track currently report ACHILLES THERAPEUTICS PL-ADR (ACHL) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in ACHILLES THERAPEUTICS PL-ADR (ACHL), this page will show fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2024 | 1 | $623,846 | 547,233 |
| Q3 2024 | 1 | $650,896 | 638,133 |
| Q2 2024 | 1 | $556,428 | 682,734 |
| Q1 2024 | 1 | $1,257 | 1,005,759 |
| Q4 2023 | 1 | $444 | 498,995 |
| Q3 2023 | 1 | $398 | 437,528 |
| Q2 2023 | 1 | $425 | 449,733 |
| Q1 2023 | 1 | $364 | 380,233 |
| Q4 2022 | 1 | $436 | 484,733 |
| Q3 2022 | 1 | $183 | 81,033 |
| Q2 2022 | 1 | $220 | 87,233 |
| Q1 2022 | 1 | $90 | 30,533 |
Related ACHL Institutional Insights:
- ACHL Institutional Ownership & Insiders Activity
- ACHL Institutional Ownership & 13F Activity
- ACHL Top Institutional Shareholders
- ACHL Institutional Buying Activity
- ACHL Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- ACHL Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings